608 related articles for article (PubMed ID: 8417138)
1. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
Saito K; Crowley JS; Markey SP; Heyes MP
J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
[TBL] [Abstract][Full Text] [Related]
5. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
Saito K; Markey SP; Heyes MP
Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
[TBL] [Abstract][Full Text] [Related]
6. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
7. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
8. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
Front Immunol; 2020; 11():31. PubMed ID: 32153556
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
[TBL] [Abstract][Full Text] [Related]
10. Temporal and spatial changes of quinolinic acid immunoreactivity in the gerbil hippocampus following transient cerebral ischemia.
Barattè S; Molinari A; Veneroni O; Speciale C; Benatti L; Salvati P
Brain Res Mol Brain Res; 1998 Aug; 59(1):50-7. PubMed ID: 9729272
[TBL] [Abstract][Full Text] [Related]
11. 4-chloro-3-hydroxyanthranilate attenuate quinolinic acid accumulation in brain following transient cerebral ischemia in the gerbil.
Saito K; Seishima M; Noma A; Suyama K; Markey SP; Heyes MP
Adv Exp Med Biol; 1996; 398():407-11. PubMed ID: 8906296
[No Abstract] [Full Text] [Related]
12. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
13. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.
Guillemin GJ; Brew BJ; Noonan CE; Takikawa O; Cullen KM
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):395-404. PubMed ID: 16008823
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.
Alberati-Giani D; Ricciardi-Castagnoli P; Köhler C; Cesura AM
J Neurochem; 1996 Mar; 66(3):996-1004. PubMed ID: 8769859
[TBL] [Abstract][Full Text] [Related]
17. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
Heyes MP; Chen CY; Major EO; Saito K
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
[TBL] [Abstract][Full Text] [Related]
18. Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues.
Heyes MP; Morrison PF
J Neurochem; 1997 Jan; 68(1):280-8. PubMed ID: 8978736
[TBL] [Abstract][Full Text] [Related]
19. Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes.
Fujigaki S; Saito K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Arch Biochem Biophys; 1998 Oct; 358(2):329-35. PubMed ID: 9784247
[TBL] [Abstract][Full Text] [Related]
20. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice.
Saito K; Markey SP; Heyes MP
Brain Res; 1991 Apr; 546(1):151-4. PubMed ID: 1830237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
